Gingrich to skip invite to Capitol Hill

Gingrich to skip invite to Capitol Hill
© Getty Images

Former Speaker Newt Gingrich (R-Ga.) will not make a requested appearance on Capitol Hill next week as speculation swirls that he may be selected as Donald TrumpDonald John TrumpJoint Chiefs chairman denies report that US is planning to keep 1K troops in Syria Kansas Department of Transportation calls Trump 'delusional communist' on Twitter Trump has privately voiced skepticism about driverless cars: report MORE's running mate.


Rep. Michael BurgessMichael Clifton BurgessDivisions emerge over House drug price bills Overnight Health Care — Presented by PCMA — Dems push Pelosi on bill allowing federal funding of abortion | Key Republican says Dems left him out of drug pricing talks | Court upholds Ohio law to defund Planned Parenthood | Trump taps acting FDA chief Key Republican says Dems left him out of process on drug pricing bills MORE (R-Texas), who chairs the House Energy and Commerce Committee's trade subcommittee, said on Wednesday that he hoped Gingrich would attend a hearing on health applications next Wednesday.

“That’s the plan,” Burgess (R-Texas) said at the time, before cautioning that "a lot" could happen in the week before the hearing.

An Energy and Commerce spokesman said the committee learned Thursday that Gingrich would not attend because of a scheduling conflict.

The buzz over Gingrich's possible appearance comes as he is being vetted to run alongside Trump, the presumptive Republican nominee for president. He also campaigned with Trump on Wednesday.

He has previously been an active defender of Trump in the press.

The former lawmaker's interest in health apps is established. He has a tie to a fund investing in health technology, according to a report this year.

“We see these breakthroughs on smartphones in every field,” he wrote in a March op-ed. “In healthcare, however, there is a growing effort by the existing, expensive systems to defend old, costly, less convenient, and slower methods by simply outlawing most of the competition, as the state of Texas recently has done to telemedicine overall.”